Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma

BACKGROUND: The prognostic value of aberrant DNA methylation of cell-free circulating DNA in plasma has not previously been evaluated in diffuse large B cell lymphoma (DLBCL). The aim of this study was to investigate if aberrant promoter DNA methylation can be detected in plasma from DLBCL patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Lasse Sommer, Hansen, Jakob Werner, Kristensen, Søren Sommer, Tholstrup, Dorte, Harsløf, Laurine Bente Schram, Pedersen, Ole Birger, De Nully Brown, Peter, Grønbæk, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015248/
https://www.ncbi.nlm.nih.gov/pubmed/27610206
http://dx.doi.org/10.1186/s13148-016-0261-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015248/
https://www.ncbi.nlm.nih.gov/pubmed/27610206
http://dx.doi.org/10.1186/s13148-016-0261-y

Ejemplares similares